Inhibition of murine lymphokine-activated killer (LAK) cell activity by adherent cells
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 121 (2) , 225-236
- https://doi.org/10.1016/0008-8749(89)90021-x
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- The regulatory effect of adherent cells on lymphokine activated killer cellsCellular Immunology, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Leukemia prevention and long-term survival of AKR mice transplanted with MHC-matched or MHC-mismatched bone marrowCellular Immunology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2Cellular Immunology, 1984
- Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2Cellular Immunology, 1982
- Prostaglandin modulation of development of cell-mediated immunity in cultureNature, 1980
- Prostaglandin-mediated regulation of the mixed lymphocyte culture and generation of cytotoxic cellsCellular Immunology, 1980
- THE MODULATING INFLUENCE OF CYCLIC NUCLEOTIDES UPON LYMPHOCYTE-MEDIATED CYTOTOXICITYThe Journal of Experimental Medicine, 1973